Working in Academia and Industry

Life science researchers like working in industry for "career development opportunities" and "financial rewards"; they like working in academia for "creative freedom" and a "stronger learning environment." These are some of the conclusions from a recently conducted study of readers of The Scientist who have held research positions in both academia and industry. The survey gathered opinions and impressions from 159 life science researchers with such dual experience. Opinions on which environment

Written byAlexander Grimwade
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Asked to rate the differences between academia and industry, readers ranked "opportunity for greater income" as the factor weighted most strongly to industry. "Pressure to publish" was deemed the strongest factor in academia. Three factors measured as fairly evenly balanced: politics, quality of science research, and overall job satisfaction.

Nearly half the respondents had returned to academia after working in industry. The most frequently cited reasons for moving to academia from industry are freedom for creativity, learning environment, and better science.

Beyond the numbers, the readers were generous in sharing their experiences of research in the two environments and in describing the challenges of transition. The survey collected more than 60 observations from readers on the differences between academia and industry, plus nearly 100 pieces of advice from researchers contemplating a change from academia to industry. Some of these comments are quoted below. The full results are available on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies